Financial Tearsheet

Company Overview

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 70 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA┬« Intragastric Balloon.

Recent Financial News

Recent SEC Filings

Management Team

Chas McKhann, Chief Executive Officer

Jeffrey G. Black, Chief Financial Officer

Christopher J. Gostout, M.D., Chief Medical Officer

John Molesphini, Executive Vice President, Operations

David Hooper, Vice President, Quality and Regulatory Affairs

Tiffanie Gilbreth, Vice President, Clinical and Medical Affairs

Mike Gutteridge, Vice President, International Sales and Marketing

Mary League, Vice President, Human Resources

Brian Szymczak, Vice President, Legal and Compliance

Boris Fischer, Vice President, Business Process and Systems

Felix L. Nieves, Vice President, Manufacturing Operations

Kirk Ellis, Vice President, US Sales

Steve Bosrock, Vice President, Marketing and Medical Education

Board of Directors

John Barr, Chairman of the Board, Altamont Capital Partners, LLC

Chas McKhann, Chief Executive Officer, Director

David C. Pacitti, Director

Bruce Robertson, Ph.D., Director

R. Kent McGaughy, Jr., Director

Rick Anderson, Director

Bill McClellan, Director

Julie Shimer, Director